Capecitabine Tablet, Film Coated
Product Images NDC 69097-948

5 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 69097-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 01)

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 01)
Chemical structure of Capecitabine, showing its molecular arrangement with specific functional groups and bonds typically seen in the compound's chemical formula.*
FDA Label Image

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 02)

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 02)
An enzymatic conversion diagram illustrating the metabolic pathway of Capecitabine. It shows Capecitabine being converted to 5'-DFCR by carboxylesterase, then to 5'-DFUR by cytidine deaminase, and finally to 5-FU by dThdPase.*
FDA Label Image

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 03)

Image (C1549b67 948e 402d 9ba4 6fc16237df8f 03)
A Kaplan-Meier survival curve chart comparing estimated probability over time (in days) between two treatment groups: Capecitabine 1,250 mg/sqm twice daily intermittent dosing (solid line) and 5-FU + Leucovorin (Mayo Regimen, dashed line). The graph shows probability decreasing with increasing time up to approximately 1,250 days.*
FDA Label Image

Capecitabine Tablets, 150mg-60 Tablets (C1549b67 948e 402d 9ba4 6fc16237df8f 04)

Capecitabine Tablets, 150mg-60 Tablets (C1549b67 948e 402d 9ba4 6fc16237df8f 04)
Label for Capecitabine 150 mg film-coated tablets, USP, by Cipla USA Inc. The label indicates the package contains 60 tablets. It includes dosage information, storage instructions, manufacturer details (MSN Laboratories Private Limited, India), and distributor address (Cipla USA, Inc., Warren, NJ). The label also directs pharmacists to dispense the patient information leaflet with each prescription.*
FDA Label Image

Capecitabine Tablets, 500mg-120 Tablets (C1549b67 948e 402d 9ba4 6fc16237df8f 05)

Capecitabine Tablets, 500mg-120 Tablets (C1549b67 948e 402d 9ba4 6fc16237df8f 05)
Capecitabine Tablets USP 500 mg film-coated oral tablets. The label indicates this prescription drug contains 120 tablets per container. It is labeled by Cipla USA Inc. and includes storage instructions, manufacturer and distributor information, and dosage advisory messages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.